Cargando…

Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes

OBJECTIVES: To report the effectiveness and long-term outcomes of intravitreal dexamethasone implantation for diabetic macular edema (DME) in vitrectomized eyes MATERIALS AND METHODS: Medical records of patients were retrospectively reviewed. Time of pars plana vitrectomy (PPV), PPV indications, int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Özdemir, Hüseyin Baran, Hasanreisoğlu, Murat, Yüksel, Murat, Ertop, Mestan, Gürelik, Gökhan, Özdek, Şengül
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961074/ https://www.ncbi.nlm.nih.gov/pubmed/31893587 http://dx.doi.org/10.4274/tjo.galenos.2019.95226

Ejemplares similares

Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis
por: Hasanreisoğlu, Murat, et al.
Publicado: (2019)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex(®)) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
por: Garlı, Murat, et al.
Publicado: (2021)

Bilateral acute Iris transillumination after COVID-19 pneumonia
por: Yüksel, Murat, et al.
Publicado: (2022)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
por: Wang, Jia-Kang, et al.
Publicado: (2021)

Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular Edema
por: Çevik, Sadık Görkem, et al.
Publicado: (2018)

Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2019)

Bilateral Anterior Uveitis Revealing Relapsing Polychondritis
por: Hasanreisoğlu, Murat, et al.
Publicado: (2019)

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
por: Freissinger, Sigrid, et al.
Publicado: (2020)

One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes
por: Liang, Youling, et al.
Publicado: (2022)

Short-term Efficacy of Intravitreal Dexamethasone Implant in Vitrectomized Eyes with Recalcitrant Diabetic Macular Edema and Prior Anti-VEGF Therapy
por: Shah, Ankoor R., et al.
Publicado: (2016)

Spontaneous Closure of Large Full-Thickness Macular Hole in a Patient with Degenerative Myopia: Case Report
por: Yüksel, Murat, et al.
Publicado: (2021)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2021)

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2022)

Effect of Dexamethasone Implant on Subfoveal Choroidal Thickness in Early Period in Vitrectomized Eyes with Diabetic Macular Edema
por: Altun, A., et al.
Publicado: (2021)

Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
por: Aoki, Ren, et al.
Publicado: (2021)

Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes
por: Novais, Eduardo A., et al.
Publicado: (2016)

Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg
por: Reibaldi, Michele, et al.
Publicado: (2012)

Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema
por: Akıncıoğlu, Dorukcan, et al.
Publicado: (2017)

Efficacy and safety of the dexamethasone implant in vitrectomized and nonvitrectomized eyes with diabetic macular edema: A systematic review and meta-analysis
por: Yuan, Qiongzhen, et al.
Publicado: (2022)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Effectiveness of Intravitreal Ranibizumab in Nonvitrectomized and Vitrectomized Eyes with Diabetic Macular Edema: A Two-Year Retrospective Analysis
por: Gedar Totuk, Ozgun Melike, et al.
Publicado: (2020)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
por: Coelho, João, et al.
Publicado: (2019)

Comparison of Inflammatory and Angiogenic Factors in the Aqueous Humor of Vitrectomized and Non-Vitrectomized Eyes in Diabetic Macular Edema Patients
por: Liang, Youling, et al.
Publicado: (2021)

Commentary: Treatment of postoperative cystoid macular edema in vitrectomized eyes: An enigma
por: Kohli, Piyush, et al.
Publicado: (2023)

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
por: Maggio, Emilia, et al.
Publicado: (2022)

Vitrectomized versus non-vitrectomized eyes in diabetic macular edema response to ranibizumab—retinal layers thickness as prognostic biomarkers
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

Defining Cystoid Macular Degeneration in Diabetic Macular Edema: An OCT-Based Single-center Study
por: Yalçın, Gökçen, et al.
Publicado: (2019)

Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant
por: Costanzo, Eliana, et al.
Publicado: (2023)

Dislocated Intraocular Lens Extraction and Iris-Claw Lens Implantation in Vitrectomized and Non-vitrectomized Eyes
por: Ersöz, M. Giray, et al.
Publicado: (2019)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
por: Thomas, Benjamin J, et al.
Publicado: (2016)

Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
por: Zarranz-Ventura, Javier, et al.
Publicado: (2020)

The Relationship Between Macular Cyst Formation and Ischemia in Diabetic Macular Edema
por: Yalçın, Nuriye Gökçen, et al.
Publicado: (2019)

Office-based intravitreal injection of expansile gas for management of macular hole in previously vitrectomized eyes
por: Apolinario, Michael A., et al.
Publicado: (2019)

Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019)

Comparison of Efficacy and Safety between Transconjunctival 23-Gauge and Conventional 20-Gauge Vitrectomy Systems in Macular Surgery
por: Goncu, Tugba, et al.
Publicado: (2012)

Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
por: Saatci, Ali Osman, et al.
Publicado: (2013)

Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
por: Matonti, Frederic, et al.
Publicado: (2012)

Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Hall, John
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d9g96kigvtmjqgecp2bgdknqfb